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Abstract
A im s—The performance of the Pastorex 
Aspergillus antigen latex agglutination test 
for the detection of galactomannan in sera 
of patients at risk for invasive aspergillosis 
was evaluated, and the impact of storage 
on the reproducibility of the antigen titre 
was tested.
Methods—During a one year period, 392 
serum samples were obtained from 46 
patients at risk for invasive aspergillosis 
and tested for the presence of ga­
lactomannan using an Aspergillus latex 
agglutination test (Pastorex). Twenty 
three positive serum samples which had 
been stored at — 20°C for 2-16 months were 
retrospectively retested* Furthermore, 
two positive serum samples were stored at
— 20°C and — 70°C and prospectively tested 
at three month intervals for a period of IS 
months.
Results—The Pastorex Aspergillus test 
was positive in eight patients with micro­
biological, radiological, or histological 
evidence for invasive aspergillosis, but was 
negative in the initial serum sample from  
five of these patients. In two patients with 
histological evidence for invasive asper­
gillosis no positive reaction was found in 
six samples. Six of 13 (45%) serum samples 
which had been stored at — 20°C for longer 
than six months had lost reactivity, while 
one o f 10 (10%) samples had lost reactivity 
when stored up to six months. Two serum  
samples which had been stored at — 20°C 
and — 70°C and prospectively retested at 
three month intervals for 15 months, 
maintained stable antigen titres. 
Conclusions—The Pastorex Aspergillus 
test is too insensitive to diagnose invasive 
aspergillosis in an early stage, but may 
contribute to the diagnosis when cultures 
remain negative and serial samples are 
obtained. To maintain a good repro­
ducibility, serum samples should be stored 
at — 70°C when the period of storage ex­
ceeds six months.
CJ Clin Pathol 1995;48:474-476)
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Invasive aspergillosis is a serious opportunistic 
infection with a high mortality rate in patients 
with compromised host defences. Since early
treatment is associated with a reduced mortality 
rate,1 reliable diagnostic tests capable of de­
tecting invasive aspergillosis in an early stage 
are of great importance. Early diagnosis is, 
however, extremely difficult. Therefore tests 
have been developed to detect Aspergillus an­
tigens in body fluids.2 Several serological tests 
to detect antigenaemia have been used, in­
cluding an enzyme linked immunoassay and a 
radioimmunoassay using purified galacto­
mannan .3' 5 Monoclonal antibodies raised 
against galactomannan6 are the basis of a rapid 
commercial latex agglutination test (Pastorex 
Aspergillus, Sanofi Diagnostics Pasteur, 
Marnes-La-Coquette, France) on serum for 
detection of circulating antigen. This test, 
which has been applied in many hospitals, 
yielded sensitivities up to 95% for patients with 
proven invasive aspergillosis,78 but has been 
reported to be of limited value because results 
became negative when testing was repeated 
after storage.910 Here3 we report our experience 
with the Pastorex Aspergillus test in patients at 
risk for invasive aspergillosis, and the results of 
a study we conducted to determine the impact 
of the duration of storage and repeated freezing 
and thawing on the antigen titre.
Methods
During a one year period, 392 serum samples 
were obtained from 46 patients at risk for 
invasive aspergillosis. At least two serum 
samples per patient were collected and pro­
cessed within 24 hours of collection, and frozen 
at —20°C until retesting. Testing of all samples 
was performed by one technician and according 
to the manufacturer’s instructions. Titration of 
positive samples was performed by successive 
twofold dilutions (1:2 to 1:32) in glycine di­
lution to buffer. To determine the impact of 
storage on the antigen titre, all positive serum 
samples were retested retrospectively.
In addition, a prospective study was per­
formed with two positive serum samples ob­
tained from one patient with a histologically 
proven disseminated infection with A  flavus. 
The impact of repeated freezing and thawing 
was studied by storing 6 ml of each serum at
— 20°C and — 70°C, respectively, for a total 
period of 15 months. At three month intervals 
the samples were thawed and the agglutination 
reaction was performed. Positive agglutination 
reactions were titrated. The impact of storage 
on the antigen titre was studied by dividing the 
remainder of the two serum samples into 20
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Table 1 Clinical evaluation and reproducibility of Pastorex Aspergillus latex agglutination test in patients at risk for invasive aspergillosis
Patient. No Agelsex
Underlying
disease
Postmortem
diagnosis
No of samples tested/ 
No of positive samples Titre
No of samples retested! 
No of positive samples Titre
Time between firstisecond 
lest (months)
1 16/F NHL, BMT Aspergillus in 4
bronchi, not 4
invasive 6/1 1:4 1/0 neg 16
2 58/M Hepatocellular Mycotic
carcinoma necrotising
bronchopneumonia 3/2 1 4 2/2 1:2 15
1 4 1:2
3 36/F AML ND 1/1 1 8 1/1 1:4 14
4 45/F Kahler, BMT Survived 18/2 1:8 1/1 .1:4 11
1:4 ND
5 30/M AML Cavitating
bronchopneumonia
invasive in lung
tissue 22/8 1 4 8/3 1:1 9
1 1 1:1
1 4 1:1
1 1 neg
1 4 neg
1 1 neg
1 4 neg
1 1 neg
6 44/F AML, BMT Mycotic
necrotising
bronchopneumonia 8/3 1:2 3/3 1:2 6
1:2 1:2
1:2 1:2
7 53/M CML, BMT ND 9/4 1:1 4/3 1:1 2
1:1 1:1
1 2 1:1
1 1 neg
8 37/M AIDS ND 3/3 1 . 1 3/3 1:1 2
1 1 1:1
1 4 1:2
NHL= non-Hodgkin’s lymphoma; BMT=bone marrow transplantation; AML,—acute myeloid leukaemia; CM L=chronic myeloid leukaemia; AIDS = acquired 
immunodeficiency syndrome; ND = not done.
Eppendorf tubes (300 pi). Ten tubes were 
stored at — 20°C and 10 at — 70°C for a total 
period of 15 months. At three m onth intervals 
two tubes stored at — 20° C and two stored at
— 70°C were thawed. The first of each pair of 
samples was used to perform the agglutination 
reaction. When positive, the second sample 
was used for titration.
The Mann-Whitney test was used to de­
termine statistical significance.
Results
A total of 392 serum samples was tested from 
46 patients suspected of invasive aspergillosis. 
Seventy serum samples were collected from 
eight patients with microbiological, radio­
logical, or histological evidence of invasive 
aspergillosis (table 1). Of these, 24 samples 
were found to be positive (titres ranged from 
1:1 to 1:8). In all cases the Pastorex Aspergillus 
test results were interpreted in the whole clin­
ical context of the patient. Antifungal therapy 
was not given in two cases (table 1, patients 
Nos 2 and 4). In five cases the antigen test was
Table 2 Effect of storage on Aspergillus antigen titre. A: Storage at —20°C and
— 70°C. Serum samples were thawed before every agglutination test. B: Storage at
— 20° C and — 70°C. Serum samples were stored until antigen titre zuas determined. 
Serum 1 (SI) and 2 (S2) were taken 3 days and 1 dayy respectivelybefore death due to 
invasive aspergillosis
Time between tests 
(months)
Storage
A JB
S I (  — 20°C) S2 (~  70°C ) S I ( - 2 0 ° C) S2 ( -  70° C )
0 1:8 1:32 1:8 1:32
3 1:8 1:16 1:8 1:16
6 1:8 1:16 1:8 1:16
9 1:8 1:16 1:8 1:16
12 1:8 1:16 1:8 1:16
15 1:8 1:16 1:8 1:16
negative at the time antifungal therapy was 
started;, but became positive during treatment 
(table 1, patients Nos 1, 3, 5, 7, and 8). In one 
case (table 1, patient No. 6) antifungal therapy 
was initiated when the Pastorex Aspergillus test 
was found positive after five successive samples 
had been negative. Culture of a broncho- 
alveolar lavage performed the same day 
yielded A  fumigatus. Two patients (acute 
lymphoblastic leukaemia and myelodysplastic 
syndrome) with histological evidence of in­
vasive aspergillosis showed no positive reaction 
in six samples. We found only one false positive 
agglutination in a sample which arrived at the 
laboratory more than 48 hours after collection. 
Eight other samples from this patient with 
chronic granulomatous disease, processed 
within six hours of collection, were negative. 
A necropsy performed on this patient, who 
died of cardiac failure, revealed no evidence of 
invasive aspergillosis.
Twenty three positive samples, which had 
been stored at “ -20oC for 2-16 months, were 
available for retesting. The results of retesting 
are shown in table 1. N ine out of 10 (90%) 
positive serum samples, which had been stored 
up to six months at — 20°C, showed a positive 
agglutination reaction when retested retro­
spectively, while seven of 13 (54%) samples 
were found positive when stored at — 2 0 °C for 
longer than six months (table 1; p = 0*067).
The effect of storage at — 20°C and — 70°C 
and of repetitive freezing and thawing of serum 
on the galactomannan antigen titre is shown 
in table 2 ,
Discussion
Since serial antigen determination has been 
shown to be of great importance ,5 we obtained
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as many serum samples as possible from 
patients at risk for invasive aspergillosis. Several 
investigators have reported the use of a number 
of methods to detect circulating Aspergillus an­
tigen in body fluids.2"511 Although antigen de­
tection appears to be highly specific, the 
sensitivity of the tests used until now has been 
quite low. The Pastorex Aspergillus test is the 
only antigen test which is commercially avail­
able, but its use to diagnose invasive asper­
gillosis in an early stage is controversial. Several 
investigators have reported a high sensitivity of 
this test, up to 95% / 8 and found that the 
Pastorex test allowed diagnosis of invasive 
aspergillosis to be made earlier in 68% of cases 
when compared to conventional methods.8 
However, other studies have shown that the 
Pastorex Aspergillus test had a low sensitivity12 
and a poor positive predictive value813 in nec­
ropsy proven cases of invasive aspergillosis. Our 
results also indicate that the 'Pastorex Aspergillus 
test is too insensitive to diagnose invasive asper­
gillosis in an early stage, but may contribute in 
the diagnosis if cultures remain negative and 
serial serum samples are obtained.
Poor reproducibility of the Pastorex Asper­
gillus test has been reported/ 10 which can make 
the interpretation of positive agglutination res­
ults difficult. Warnock et al9 retested 10 positive 
serum samples which had been stored for three 
days to 10 months at — 30°C, and found that 
all samples had become negative, and Knight et 
af°  retested 32 positive samples with a different 
batch and found loss of reactivity in 14 samples. 
However, these reactions could have been false 
positive as the manufacturer's instructions were 
not followed.14 In the present study, serum 
samples which had been stored at — 20°C for 
more than six months tended to lose reactivity. 
Although, because of the limited number of 
positive samples available, the difference was 
not statistically significant in comparison to 
serum samples stored for less than six months, 
it shows a trend towards loss of reactivity when 
serum samples are stored at — 20°C for long 
periods of time. Also, the titre found at retesting 
tended to be lower when the period of storage 
became longer.
The serum samples which were stored at
— 20°C and —70°C and prospectively retested 
at three m onth intervals were all found to be 
positive with stable antigen titres. Repeated 
freezing and thawing of these serum samples 
(table 2, A) did not appear to have an effect 
on the reproducibility. However, to maintain a 
good reproducibility in the Pastorex Aspergillus 
test, we recommend that serum samples should 
be stored at — 70°C when the period of storage 
exceeds six months.
In the absence of better commercial antigen 
detection, the Pastorex Aspergillus test remains
useful, although a better test needs to be de­
veloped. Other techniques, including DNA  
based assays, may contribute in the diagnosis 
of invasive aspergillosis in an early stage. Several 
investigators have reported the use of the poly­
merase chain reaction (PCR) for the detection 
of Aspergillus DNA in BAL fluid.15-18 The PCR 
showed a very high sensitivity and specificity 
in patients at high risk for invasive aspergillosis. 
However, the value of the PCR in the diagnosis 
of this condition remains to be established and 
prospective evaluations are now being per­
formed. The diagnosis of invasive aspergillosis 
is difficult and demands a multidisciplinary 
approach. The implementation and com­
bination of novel or improved methods, for 
example PCR and antigen detection, to diag­
nose invasive aspergillosis in an early stage or 
in guiding treatment may improve the clinical 
outcome of this disease.
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